Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Burzynski"


2 mentions found


The Avro Arrow, also known as the CF-105, had a lot resting on its wings. To this day, 65 years later, the Avro Arrow remains one of Canada’s biggest collective regrets and still fuels public discourse, as recently unveiled documents have shed some light on exactly what happened to the doomed project. As a result, thousands of jobs were lost and Avro Canada eventually collapsed entirely. Another says Canadian intelligence analysts deliberately misconstrued information to support a decision that the government had essentially made, providing an excuse for it. “They decided they wanted a big new fancy plane, so they came up with all the operational requirements largely in isolation, without really paying attention to what the reports were saying.”By the late 1950s, he adds, the Arrow arrow was getting very expensive and quite delayed.
Persons: , Richard Mayne, ” Mayne, , Mayne, didn’t, John Diefenbaker, Alan Barnes, Barnes, Keith Beaty, Dan Aykroyd, Crawford Gordon, Arrow, John Burzynski, ” Burzynski, Burzynski Organizations: CNN, Avro, Royal Canadian Air Force, Arrows, Soviet Union, DND, ” Aircraft, , Sputnik, , CF, NASA, Ottawa’s Carleton University, Soviets, Chiefs, Staff Committee, Canadian Air and Space Museum, Toronto Star, CBC, Canadian Broadcasting Corporation, Reynolds, Springbank Airport, Canada Aviation, Space Museum, Canadian Aviation and Space Museum, Arrow Locations: Canada, Soviet, Soviet Union, North America, Avro Canada, American, United, United States, Canadian, Wetaskiwin , Alberta, Muskoka , Ontario, Calgary –, Ottawa, Lake Ontario
Online claims that the drugs are a cancer “cure” and that any of them has been FDA-approved are misleading, a cancer expert and an FDA official told Reuters. A video viewed more than 135,000 times on Facebook begins with: “THIS CURE FOR CANCER WAS DISCOVERED 42 YEARS AGO…” (here). A search of the database also shows no reported Phase 3 or randomized controlled studies on any antineoplastons as a cancer treatment. To approve a drug, FDA requires phase 3 studies to demonstrate “whether or not a product offers a treatment benefit to a specific population” (here). Cancer Research UK and the Memorial Sloan Kettering Cancer Center also caution about the lack of evidence for antineoplastons in treating cancer (here), (here).
Total: 2